✦ LIBER ✦

Docetaxel-induced lymphopenia in patients with solid tumors : A prospective phenotypic analysis

✍ Scribed by Athanasios Kotsakis; Evanthia Sarra; Maria Peraki; Michael Koukourakis; Stella Apostolaki; John Souglakos; Emmanuel Mavromanomakis; John Vlachonikolis; Vassilis Georgoulias

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 128 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000915)89:6<1380::aid-cncr23>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of gemcitabine and docet

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and